Pharma Mar SA (ES:PHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharma Mar SA has temporarily suspended its liquidity contract with JB CAPITAL MARKETS to implement a share buyback program authorized by shareholders. The contract suspension will begin after the market closes on May 3, 2024, following a series of detailed transactions in Q2 2024. These operations included both purchases and sales of the company’s own shares, affecting the stock’s liquidity and quotation.
For further insights into ES:PHM stock, check out TipRanks’ Stock Analysis page.